Paper41113636
Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy.
Miszkiewicz-Golec J and 5 others. Front Microbiol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy. Papers, record 41113636. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41113636
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18154538 | Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. | Clin Microbiol Infect | 2008 | https://conductscience.org/library/papers/18154538 | PubMed |
| 2 | 7489494 | Inhibition of the hammerhead ribozyme by neomycin. | RNA | 1995 | https://conductscience.org/library/papers/7489494 | PubMed |
| 3 | 12718910 | Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. | Mol Ther | 2003 | https://conductscience.org/library/papers/12718910 | PubMed |
| 4 | 15025910 | The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. | Oligonucleotides | 2003 | https://conductscience.org/library/papers/15025910 | PubMed |
| 5 | 24137305 | Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria. | Exp Ther Med | 2013 | https://conductscience.org/library/papers/24137305 | PubMed |
| 6 | 3487247 | Synergism and antagonism in double beta-lactam antibiotic combinations. | Am J Med | 1986 | https://conductscience.org/library/papers/3487247 | PubMed |
| 7 | 7505618 | The hammerhead RNA domain, a model ribozyme. | Biochim Biophys Acta | 1993 | https://conductscience.org/library/papers/7505618 | PubMed |
| 8 | 8781957 | Detection of hammerhead ribozyme-mediated cleavage and reduced expression of LacZ' mRNA in E. coli. | Genet Anal | 1996 | https://conductscience.org/library/papers/8781957 | PubMed |
| 9 | 30534121 | Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30534121 | PubMed |
| 10 | 21097888 | Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21097888 | PubMed |
| 11 | 10446190 | Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10446190 | PubMed |
| 12 | 8948630 | In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II. | Nucleic Acids Res | 1996 | https://conductscience.org/library/papers/8948630 | PubMed |
| 13 | 22539264 | Automated 3D structure composition for large RNAs. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22539264 | PubMed |
| 14 | 10371033 | Ribozymes: the characteristics and properties of catalytic RNAs. | FEMS Microbiol Rev | 1999 | https://conductscience.org/library/papers/10371033 | PubMed |
| 15 | 10890453 | Plasmid effects on Escherichia coli metabolism. | Crit Rev Biotechnol | 2000 | https://conductscience.org/library/papers/10890453 | PubMed |
| 16 | 11454858 | An extra nucleotide in the consensus catalytic core of a viroid hammerhead ribozyme: implications for the design of more efficient ribozymes. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11454858 | PubMed |
| 17 | 31296387 | Structure and dynamics of human and bacterial acyl carrier proteins and their interactions with fatty acid synthesis proteins. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31296387 | PubMed |
| 18 | 28794451 | Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/28794451 | PubMed |
| 19 | 8744570 | VMD: visual molecular dynamics. | J Mol Graph | 1996 | https://conductscience.org/library/papers/8744570 | PubMed |
| 20 | 11024182 | Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/11024182 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41113636
GET https://conductscience.org/api/papers/v1/41113636/references?page=2